Tipping Points and Endogenous Determinants of Nigrostriatal Degeneration by MPTP
Dateien
Datum
Autor:innen
Herausgeber:innen
ISSN der Zeitschrift
Electronic ISSN
ISBN
Bibliografische Daten
Verlag
Schriftenreihe
Auflagebezeichnung
URI (zitierfähiger Link)
DOI (zitierfähiger Link)
Internationale Patentnummer
Link zur Lizenz
Angaben zur Forschungsförderung
Projekt
Open Access-Veröffentlichung
Sammlungen
Core Facility der Universität Konstanz
Titel in einer weiteren Sprache
Publikationstyp
Publikationsstatus
Erschienen in
Zusammenfassung
The neurotoxicant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) causes a Parkinson's disease (PD)-like syndrome by inducing degeneration of nigrostriatal dopaminergic neurons. Studies of the MPTP model have revealed the pathomechanisms underlying dopaminergic neurodegeneration and facilitated the development of drug treatments for PD. In this review, we provide an update on MPTP bioactivation and biodistribution, reconcile the distinct views on energetic failure versus reactive oxygen species (ROS) formation as main drivers of MPTP-induced neurodegeneration, and describe recently identified intrinsic features of the nigrostriatal system that make it particularly vulnerable to MPTP. We discuss these new perspectives on the endogenous tipping points of tissue homeostasis and the drivers responsible for vicious cycles in relation to their relevance for the development of novel intervention strategies for PD.
Zusammenfassung in einer weiteren Sprache
Fachgebiet (DDC)
Schlagwörter
Konferenz
Rezension
Zitieren
ISO 690
SCHILDKNECHT, Stefan, Donato A. DI MONTE, Regina PAPE, Kim TIEU, Marcel LEIST, 2017. Tipping Points and Endogenous Determinants of Nigrostriatal Degeneration by MPTP. In: Trends in Pharmacological Sciences. 2017, 38(6), pp. 541-555. ISSN 0165-6147. eISSN 1873-3735. Available under: doi: 10.1016/j.tips.2017.03.010BibTex
@article{Schildknecht2017-06Tippi-39116, year={2017}, doi={10.1016/j.tips.2017.03.010}, title={Tipping Points and Endogenous Determinants of Nigrostriatal Degeneration by MPTP}, number={6}, volume={38}, issn={0165-6147}, journal={Trends in Pharmacological Sciences}, pages={541--555}, author={Schildknecht, Stefan and Di Monte, Donato A. and Pape, Regina and Tieu, Kim and Leist, Marcel} }
RDF
<rdf:RDF xmlns:dcterms="http://purl.org/dc/terms/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bibo="http://purl.org/ontology/bibo/" xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:void="http://rdfs.org/ns/void#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/39116"> <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-06-06T08:04:42Z</dc:date> <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/> <dc:language>eng</dc:language> <dcterms:rights rdf:resource="https://rightsstatements.org/page/InC/1.0/"/> <dc:contributor>Leist, Marcel</dc:contributor> <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/39116/1/Schildknecht_2-11h01fv3yk3t65.pdf"/> <foaf:homepage rdf:resource="http://localhost:8080/"/> <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/39116/1/Schildknecht_2-11h01fv3yk3t65.pdf"/> <dc:contributor>Schildknecht, Stefan</dc:contributor> <dc:creator>Leist, Marcel</dc:creator> <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/39116"/> <dc:contributor>Pape, Regina</dc:contributor> <dc:creator>Schildknecht, Stefan</dc:creator> <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-06-06T08:04:42Z</dcterms:available> <dcterms:issued>2017-06</dcterms:issued> <dcterms:abstract xml:lang="eng">The neurotoxicant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) causes a Parkinson's disease (PD)-like syndrome by inducing degeneration of nigrostriatal dopaminergic neurons. Studies of the MPTP model have revealed the pathomechanisms underlying dopaminergic neurodegeneration and facilitated the development of drug treatments for PD. In this review, we provide an update on MPTP bioactivation and biodistribution, reconcile the distinct views on energetic failure versus reactive oxygen species (ROS) formation as main drivers of MPTP-induced neurodegeneration, and describe recently identified intrinsic features of the nigrostriatal system that make it particularly vulnerable to MPTP. We discuss these new perspectives on the endogenous tipping points of tissue homeostasis and the drivers responsible for vicious cycles in relation to their relevance for the development of novel intervention strategies for PD.</dcterms:abstract> <dcterms:title>Tipping Points and Endogenous Determinants of Nigrostriatal Degeneration by MPTP</dcterms:title> <dc:creator>Di Monte, Donato A.</dc:creator> <dc:contributor>Tieu, Kim</dc:contributor> <dc:rights>terms-of-use</dc:rights> <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/> <dc:creator>Tieu, Kim</dc:creator> <dc:contributor>Di Monte, Donato A.</dc:contributor> <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/> <dc:creator>Pape, Regina</dc:creator> </rdf:Description> </rdf:RDF>